Skip to Main Content

Paper Details

Genetic Variants of <i>VEGFA</i> and <i>FLT4</i> Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib.
Cancer Res
21
2019
56 genes, FLT4, FLT4 rs307826, Germline, ITGAV rs3816375, Patients, RCC, RCC cell lines, Renal Cell Carcinoma, Sorafenib, VEGFA, VEGFA rs1885657, VEGFA rs3024987, VEGFA rs58159269, VEGFR-3, WWOX rs8047917, endothelial, endothelial cell, germline, mRCC, malignancies, metastatic renal cell carcinoma, patients, rs307826, rs58159269, sorafenib
Author NameAffiliation
Andrew D SkolThe University of Chicago
Andrew D SkolThe University of Chicago
Kari AlitaloWihuri Research Institute and University of Helsinki
  • 1 - 3

Datasets

Release 1.2